Summary
Johnson & Johnson (JNJ) announced the completion of significant public offerings for both U.S. Dollar and Euro denominated notes on May 20, 2024. This filing details the issuance of approximately $4.0 billion in U.S. Dollar notes across various maturities (2029, 2031, 2034, and 2054) with coupon rates ranging from 4.800% to 5.250%. Additionally, JNJ issued approximately €2.5 billion in Euro notes with maturities in 2032, 2036, and 2044, carrying coupon rates from 3.200% to 3.550%. These offerings, conducted under the company's existing Form S-3 registration statement, represent a strategic move to raise capital. Investors should note that this transaction primarily relates to debt financing and does not involve equity issuance or significant operational updates. The filings also include details of the underwriting agreements with major financial institutions like J.P. Morgan, BofA Securities, and Citigroup.
Key Highlights
- 1Completion of substantial U.S. Dollar note offerings totaling approximately $4.0 billion.
- 2Issuance of Euro notes amounting to approximately €2.5 billion.
- 3Note maturities range from 5 years (2029) to 30 years (2054) for USD, and up to 20 years (2044) for EUR.
- 4Coupon rates for USD notes range from 4.800% to 5.250%.
- 5Coupon rates for EUR notes range from 3.200% to 3.550%.
- 6Offerings were made under Johnson & Johnson's existing Form S-3 registration statement.
- 7Details provided on underwriting agreements with key investment banks.